Carter Bankshares, Inc.
NASDAQ:CAREBanks - Regional
-$0.20 today
- Market cap
- $635.59M
- Beta
- 0.55
- P/E (TTM)
- 6.2
- EPS (TTM)
- $4.95
- Dividend yield
- 0.33%
Volume 0.19M
Average 0.32M
CARE Selling, General & Admin
Overhead costs of running the business, including sales, marketing, management, and administrative staff.
Carter Bankshares, Inc.NASDAQ: CARE
Selling, General & Admin · Q1 FY2026 · quarter ended Mar 2026
Selling, general & admin growth accelerates
Q1 FY2026 selling, general & admin of $19.78M rose 23.6% year over year, ahead of the +9.6% change in trailing-twelve-month selling, general & admin. Sequentially, it fell 2.7% from the prior quarter. Over 3 fiscal years it compounded at +10.5% a year.
Context
- Selling, general & admin amounted to 29.6% of revenue in FY2025, up 1.8 pp from a year earlier.
- Selling, general & admin increased in 3 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether selling, general & admin reaches the consensus estimate from 1 analysts of $79.91M (+6.0%) for the fiscal year ending Dec 2026, a slowdown from the +13.1% reported in FY2025.
Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterMar 2026
- $19.78M-2.7% QoQ
- Last fiscal yearDec 2025
- $75.36M+13.1% YoY
- LTMMar 2026
- $72.77M+9.6% YoY
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
Selling, General & Admin history
USD · from the income statement
- Latest · FY2025
- 75.36M USD
- Year-over-year change
- +13.1%
- 4-year CAGR
- +7.1%
| Period | Period end | Selling, General & Admin | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 75.36M | +13.1% |
| FY2024 | 2024-12-31 | 66.65M | +6.7% |
| FY2023 | 2023-12-31 | 62.45M | +11.8% |
| FY2022 | 2022-12-31 | 55.85M | -2.5% |
| FY2021 | 2021-12-31 | 57.27M | — |
Selling, General & Admin vs competitors
How CARE compares with its peers on the latest reported figures
- CARE's LTM Mar 2026 selling, general & admin of $72.77M is the 3rd highest of the 11 companies compared; the peer median is $47.17M.
- Its year-over-year change of +9.6% is the 8th highest of 11, against a peer median of +14.7%.
- Selling, general & admin amounts to 22.7% of revenue for CARE, versus a peer median of 23.3%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | $87.75M | +45.1% | +13.2% | 36.1% | |
| LTM Mar 2026 | $86.94M | -11.0% | -13.7% | 14.1% | |
| LTM Mar 2026 | $72.77M | +9.6% | +10.5% | 22.7% | |
| LTM Mar 2026 | $66.31M | +14.3% | +10.4% | 37.9% | |
| LTM Mar 2026 | $51.71M | +14.1% | +23.0% | 20.8% | |
| LTM Mar 2026 | $47.85M | -21.2% | -5.6% | 33.2% | |
| LTM Mar 2026 | $46.49M | -17.4% | +3.8% | 24.6% | |
| LTM Mar 2026 | $44.19M | +690.6% | +6.4% | 21.5% | |
| LTM Mar 2026 | $39.27M | +33.2% | +10.9% | 18.5% | |
| LTM Mar 2026 | $27.02M | +23.4% | -0.5% | 22.0% | |
| LTM Mar 2026 | $23.93M | +15.2% | +12.1% | 27.8% | |
| Peer median (excluding CARE) | $47.17M | +14.7% | +8.4% | 23.3% | |
Competitors are the stored peer set for CARE. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 156.38M | 179.15M | 211.82M | 239.67M | 254.63M |
| Cost of Revenue | 24.8M | 23.18M | 80.51M | 102.23M | 97.57M |
| Gross Profit | 131.58M | 155.97M | 131.31M | 137.45M | 157.06M |
| Gross Margin | 84.1% | 87.1% | 62.0% | 57.3% | 61.7% |
| Research & Development | 0 | 0 | 0 | 0 | 0 |
| Selling, General & Admin | 57.27M | 55.85M | 62.45M | 66.65M | 75.36M |
| Operating Expenses | 95.89M | 94.25M | 102.59M | 106.58M | 117.05M |
| Depreciation & Amortization | 6.23M | 6.06M | 6.25M | 7.06M | 7.86M |
| EBITDA | 41.93M | 67.78M | 34.97M | 37.92M | 47.86M |
| EBITDA Margin | 26.8% | 37.8% | 16.5% | 15.8% | 18.8% |
| Operating Income | 35.7M | 61.72M | 28.72M | 30.87M | 40M |
| Operating Margin | 22.8% | 34.4% | 13.6% | 12.9% | 15.7% |
| Interest Income | 133.78M | 160.03M | 194.96M | 220.72M | 232.22M |
| Interest Expense | 22.71M | 20.25M | 74.11M | 107.27M | 101.4M |
| Other Income / Expenses | 0 | 0 | 0 | 0 | 0 |
| Income Before Tax | 35.7M | 61.72M | 28.72M | 30.87M | 40M |
| Pre-Tax Margin | 22.8% | 34.4% | 13.6% | 12.9% | 15.7% |
| Income Tax Expense | 4.11M | 11.6M | 5.34M | 6.35M | 8.64M |
| Net Income | 31.59M | 50.12M | 23.38M | 24.52M | 31.36M |
| Net Margin | 20.2% | 28.0% | 11.0% | 10.2% | 12.3% |
| EPS (Basic) | 1.20 | 2.03 | 1.00 | 1.06 | 1.40 |
| EPS (Diluted) | 1.20 | 2.03 | 1.00 | 1.06 | 1.40 |
| Weighted Avg Shares | 26.34M | 24.6M | 23.24M | 23.24M | 22.46M |
| Weighted Avg Shares (Diluted) | 26.34M | 24.6M | 23.24M | 23.24M | 22.46M |
Carter Bankshares, Inc.
NASDAQ:CARE
Intrinsic Alpha fair value
Locked
Current Price
$28.93
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.